Literature DB >> 15934142

Structure-activity relationships of tyrosinase inhibitory combinatorial library of 2,5-disubstituted-1,3,4-oxadiazole analogues.

Mahmud Tareq Hassan Khan1, Muhammad Iqbal Choudhary, Khalid Mohammed Khan, Mubeen Rani.   

Abstract

Here the tyrosinase inhibition studies of library of 2,5-disubstituted-1,3,4-oxadiazoles have been reported and their structure-activity relationship (SAR) also have been discussed. The library of the oxadiazoles was synthesized under the microwave irradiation and was structures of these were characterized by different spectral techniques. From this study it could be concluded that for a better inhibition of tyrosinase, electronegative substitution is essential as most probably the active site of the enzyme contain some hydrophobic site and position is also very important for the inhibition purposes due to the conformational space. The electronegativity of the compounds is somewhat proportional to the inhibitory activity. The compound 3e (3'-[5-(4'-bromophenyl)-1,3,4-oxadiazol-2-yl]pyridine) exhibited most potent (IC50 = 2.18 microM) inhibition against the enzyme tyrosinase which is more potent than the standard potent inhibitor L-mimosine (IC50 = 3.68 microM). This molecule can be the best candidate as a lead compound for further development of drug for the treatments of several skin disorders.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15934142     DOI: 10.1016/j.bmc.2005.03.012

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  8 in total

1.  5-[1-(3,4-Dichloro-phen-oxy)eth-yl]-1,3,4-oxadiazole-2(3H)-thione hemihydrate.

Authors:  Tashfeen Akhtar; M Khawar Rauf; Shahid Hameed; Xiaoming Lu
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-08-08

2.  In vitro effect of ozagrel on mushroom tyrosinase.

Authors:  Shu-Bai Li; Yong Xue; Xin-Yu Lv; Hua-Li Nie; Li-Min Zhu; Hai-Tao Zhang; Tao Qiu; Li-Ming Zhou
Journal:  Protein J       Date:  2009-05       Impact factor: 2.371

3.  Growth inhibition and induction of apoptosis in MCF-7 breast cancer cells by a new series of substituted-1,3,4-oxadiazole derivatives.

Authors:  Akhilesh Kumar; Saritha S D'Souza; S L Gaonkar; K M L Rai; Bharathi P Salimath
Journal:  Invest New Drugs       Date:  2008-01-29       Impact factor: 3.850

4.  (S)-N-{1-[5-(4-Chloro-benzyl-sulfanyl)-1,3,4-oxadiazol-2-yl]eth-yl}-4-methyl-benzene-sulfonamide.

Authors:  Tayyaba Syed; Shahid Hameed; Peter G Jones
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-09-30

5.  Synthesis of new oxadiazol-phthalazinone derivatives with anti-proliferative activity; molecular docking, pro-apoptotic, and enzyme inhibition profile.

Authors:  Mohamed H Hekal; Abeer M El-Naggar; Fatma S M Abu El-Azm; Wael M El-Sayed
Journal:  RSC Adv       Date:  2020-01-22       Impact factor: 4.036

Review 6.  An updated review of tyrosinase inhibitors.

Authors:  Te-Sheng Chang
Journal:  Int J Mol Sci       Date:  2009-05-26       Impact factor: 6.208

7.  Crystal structure and Hirshfeld surface analysis of 1-(4-chloro-phen-yl)-2-{[5-(4-chloro-phen-yl)-1,3,4-oxa-diazol-2-yl]sulfan-yl}ethanone.

Authors:  Rajesh Kumar; Shafqat Hussain; Khalid M Khan; Shahnaz Perveen; Sammer Yousuf
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2017-03-17

Review 8.  Synthetic approaches and pharmacological activity of 1,3,4-oxadiazoles: a review of the literature from 2000-2012.

Authors:  Cledualdo Soares de Oliveira; Bruno Freitas Lira; José Maria Barbosa-Filho; Jorge Gonçalo Fernandez Lorenzo; Petrônio Filgueiras de Athayde-Filho
Journal:  Molecules       Date:  2012-08-27       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.